r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

CL

Column Group IV GP, LP

Insider · 10% owner · EIKN

Column Group IV GP, LP files insider transactions with the SEC as a 10% owner of Eikon Therapeutics (EIKN). We hold 2 disclosed purchases and sales filed since 31 May 2022, 1 of them in the last 90 days.

  • Files forEIKN
  • Disclosed buys and sells2 in all, 1 in the last 90 days
  • Last disclosure8 September 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 6 February 2026 — 3 September 202610% owner · Eikon Therapeutics (EIKN)18 Form 4 lines · source: SEC Form 4
  • Filed 26 May 2022 — 9 June 202210% owner · Ngm Biopharmaceuticals (NGM)6 Form 4 lines · source: SEC Form 4

Everything they disclosed

24 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.